Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Applied Therapeutics Inc (NQ: APLT )

1.460 +0.010 (+0.69%)
Streaming Delayed Price Updated: 2:14 PM EDT, Jun 8, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 98,150
Open 1.440
Bid (Size) 1.460 (1)
Ask (Size) 1.490 (1)
Prev. Close 1.450
Today's Range 1.380 - 1.510
52wk Range 0.4995 - 2.180
Shares Outstanding 57,849,292
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Govorestat (AT-007) Receives Orphan Medicinal Product Designation from the EMA for Treatment of SORD Deficiency
From Applied Therapeutics
Via GlobeNewswire
Applied Therapeutics Reports First Quarter 2023 Financial Results
From Applied Therapeutics
Via GlobeNewswire

Performance

YTD
+94.10%
+94.10%
1 Month
-14.62%
-14.62%
3 Month
+49.01%
+49.01%
6 Month
+73.81%
+73.81%
1 Year
+18.70%
+18.70%

More News

Read More
7 Hot Growth Stocks Poised to Triple in 2023
Via InvestorPlace
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Why First Republic Bank Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Why IDEAYA Biosciences Shares Are Trading Higher By Around 27%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Applied Therapeutics' Investigational Drug Shows Clinical Benefit In Rare Metabolic Disorder, Chalks Out FDA Submission Plans
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Applied Therapeutics Announces Clinical Benefit of Govorestat (AT-007) in ACTION-Galactosemia Kids Trial; Company Plans to Meet with FDA Regarding Potential NDA Submission
From Applied Therapeutics
Via GlobeNewswire
Applied Therapeutics, Inc. Announces $30 Million Private Placement of Equity
From Applied Therapeutics
Via GlobeNewswire
Applied Therapeutics Reports Fourth Quarter and Year-end 2022 Financial Results
From Applied Therapeutics
Via GlobeNewswire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
Applied Therapeutics to Present at the Cowen 43rd Annual Health Care Conference
From Applied Therapeutics
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Why Universal Electronics Shares Are Trading Lower By 30%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why Nogin Shares Are Trading Higher By Around 77%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Applied Therapeutics Reveals Pivotal Study Data In Hereditary Neuropathy
Via Benzinga
Applied Therapeutics Announces Positive Sorbitol Reduction Data From the Ongoing Phase 3 INSPIRE Trial in Sorbitol Dehydrogenase (SORD) Deficiency
From Applied Therapeutics
Via GlobeNewswire
Applied Therapeutics to Present at the SVB Securities Global Biopharma Conference
From Applied Therapeutics
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.